Showing results (101-110 of 116) with videos related to
Sort By:
Pageof 12
Plos One|December 3, 2015
Combination of a Selective HSP90α/β Inhibitor and a RAS-RAF-MEK-ERK Signaling Pathway Inhibitor Triggers Synergistic Cytotoxicity in Multiple Myeloma CellsRikio Suzuki, Shohei Kikuchi, Takeshi Harada, et al.Plos One|November 11, 2011
Glycolysis inhibition inactivates ABC transporters to restore drug sensitivity in malignant cellsAyako Nakano, Daisuke Tsuji, Hirokazu Miki, et al.Blood Advances|January 4, 2018
TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effectsHirofumi Tenshin, Jumpei Teramachi, Asuka Oda, et al.Journal of Clinical Medicine|July 12, 2025
Mean Corpuscular Volume Is Correlated with Liver Fibrosis Defined by Noninvasive Blood Biochemical Indices in Individuals with Metabolic Disorders Aged 60 Years or OlderYousuke Kaneko, Yutaka Kawano, Saki Kawata, et al.Scientific Reports|October 13, 2018
An extracellular [NiFe] hydrogenase mediating iron corrosion is encoded in a genetically unstable genomic island in Methanococcus maripaludisHirohito Tsurumaru, Naofumi Ito, Koji Mori, et al.Antioxidants (Basel, Switzerland)|January 21, 2023
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2Yoshiki Higa, Masahiro Hiasa, Hirofumi Tenshin, et al.Ejhaem|August 21, 2023
Therapeutic efficacy of the resorcylic acid lactone LL-Z1640-2 for adult T-cell leukaemia/lymphomaMasahiro Oura, Takeshi Harada, Asuka Oda, et al.British Journal of Haematology|January 13, 2018
Unique anti-myeloma activity by thiazolidine-2,4-dione compounds with Pim inhibiting activityShiro Fujii, Shingen Nakamura, Asuka Oda, et al.Oncotarget|September 15, 2016
A vicious cycle between acid sensing and survival signaling in myeloma cells: acid-induced epigenetic alterationRyota Amachi, Masahiro Hiasa, Jumpei Teramachi, et al.Clinical & Translational Immunology|January 26, 2022
TGF-β-activated kinase-1 inhibitor LL-Z1640-2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-α and RANKL expressionHirofumi Tenshin, Jumpei Teramachi, Mohannad Ashtar, et al.Pageof 12